membrane
The development of a bipolar membrane with enhanced properties through specific AEL and CEL compositions and production methods addresses the limitations of existing membranes, providing improved durability and cost-effectiveness for applications like electrodialysis.
Patent Information
- Application Number
- JP2023519630
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-09-30
- Filing Date
- 2021-09-27
- Publication Date
- 2025-08-19
- Estimated Expiration
- 2041-09-27
AI Technical Summary
Existing bipolar membranes lack high permselectivity, low electrical resistance, good mechanical strength, and stability at extreme pH, and are not produced efficiently and cost-effectively.
A membrane comprising an anion exchange layer (AEL) and a cation exchange layer (CEL) with specific chemical compositions and formulations, including curable compounds and porous supports, to enhance properties such as permselectivity and mechanical strength, and a method for producing these layers through controlled curing and hydrolysis.
The resulting membranes exhibit improved durability, low swelling in acidic and basic media, and are produced quickly and inexpensively, making them suitable for applications like electrodialysis and acid/base generation.
Smart Images

Figure 0007725574000001 
Figure 0007725574000002 
Figure 0007725574000003
Abstract
Description
[Technical Field]
[0001] The present invention relates to membranes (including bipolar membranes), and methods for their preparation and uses. [Background technology]
[0002] Ion exchange membranes are used in electrodialysis, electrodialysis reversal, electrolysis, diffusion dialysis, and several other processes. Typically, the transport of ions through the membrane occurs under the influence of a driving force such as an ion concentration gradient or, alternatively, an electric potential gradient.
[0003] Ion exchange membranes are generally classified as cation exchange membranes (CEMs) or anion exchange membranes (AEMs) depending on their predominant charge. Cation exchange membranes contain negatively charged groups that allow cations to pass but reject anions, while anion exchange membranes contain positively charged groups that allow anions to pass but reject cations. Bipolar membranes (BPMs) have both a cation layer and an anion layer.
[0004] Some bipolar membranes include a porous support that provides mechanical strength. Such membranes are often called "composite bipolar membranes" due to the presence of anionic and cationic polymers that differentiate between ions and a porous support that provides mechanical strength. Summary of the Invention [Problem to be solved by the invention]
[0005] There is a need to provide bipolar membranes with improved properties, such as high permselectivity, low electrical resistance, good mechanical strength, and stability at extreme pH. Ideally, such bipolar membranes can be produced quickly, efficiently, and inexpensively. [Means for solving the problem]
[0006] According to a first aspect of the present invention, there is provided a membrane comprising an anion exchange layer (AEL) and a cation exchange layer (CEL), wherein the CEL is represented by formula (I):
[0007] [ka]
[0008] (In the formula, X is a group of the formula -OC n H 2n+1 , or -OC q H 2q-1 wherein n has a value of 1 to 6 and q has a value of 5 or 6; wherein m has a value of 1 or 2). DETAILED DESCRIPTION OF THE INVENTION
[0009] In this document (including the claims), the verb "comprise" and its conjugations are used in their open-ended sense to mean that the items following this word are included, but not that items not specifically mentioned are excluded. In addition, reference to an element by the indefinite article "a" or "an" does not exclude the possibility that more than one of the element is present, unless the context clearly requires that one and only one of the element is present. Thus, the indefinite article "a" or "an" typically means "at least one." A composition used to form an AEL is often abbreviated herein as an "AEL composition." Similarly, a composition used to form a layer that is or will become a CEL is often abbreviated herein as a "CEL composition."
[0010] The -SO2X group shown in formula (I) can be converted to an anionic group and is therefore useful for providing an anionic group to the CEL. The -SO2X group in formula (I), where X is as defined above, is preferred when X is Cl or OSO2R, where R is C, due to their low reactivity with nucleophiles. 1~6 -Alkyl, or C 6~12 -aryl). As a result, compounds of formula (I) (wherein X is as defined above) can be prepared by adding a methyl group to a compound of formula (I) where X is Cl or OSOR (wherein R is C 1~6 -Alkyl, or C 6~12 -aryl) have better stability than the corresponding compounds.
[0011] Compounds of formula (I) are known and many such compounds are commercially available. In preferred embodiments, m has a value of 1 or 2, n has a value of 2 (ie, X is ethyloxy), or q has a value of 6 (ie, X is cyclohexyloxy).
[0012] Component (a) is preferably highly miscible with non-polar compounds, such as uncharged aromatic molecules, for example, divinylbenzene. Compounds of formula (I) include the following:
[0013] [ka]
[0014] (Wherein R represents -OC n H 2n+1 or -OC q H 2q-1 wherein n has a value of 1 to 6 and q has a value of 5 or 6, for example, methoxy, ethoxy, propoxy, tert-butoxy, or cyclohexyloxy.
[0015] The curable composition from which the CEL may be obtained (i.e., the "CEL composition") preferably comprises the following components: (a) a compound of formula (I) (as defined above); and optionally (b) a compound containing at least two ethylenically unsaturated groups; and optionally (c) a non-aqueous solvent; optionally (d) a radical initiator; optionally (e) an anionic monomer containing one and only one ethylenically unsaturated group; Includes.
[0016] Preferably, the CEL composition comprises component (b) and / or component (c). Preferably, the CEL composition comprises at least one, more preferably at least two, particularly preferably at least three, and more particularly preferably all four of components (b), (c), (d), and (e) (as defined above).
[0017] Preferably, the CEL composition comprises: (a) 20 to 88 wt% of component (a); (b) 10 to 60 wt% of component (b); (c) 0 to 30 wt% of component (c); (d) 0 to 2 wt% of component (d); (e) 0 to 15 wt% of component (e) Includes.
[0018] Preferred embodiments for the compounds of formula (I) used as component (a) in the CEL compositions are as described above in relation to the first aspect of the invention. Preferably, the CEL composition comprises 20 to 88 wt %, more preferably 30 to 80 wt %, and most preferably 40 to 75 wt % of component (a).
[0019] Component (b) typically functions as a crosslinker and can desirably provide a CEL layer with a high crosslink density, which preferably limits swelling of the bipolar membrane when in an aqueous environment.
[0020] Preferably, component (b) contains an aromatic group, such as a phenyl or phenylene group (eg, as found in styrene). Preferred ethylenically unsaturated groups include (meth)acrylic acid groups and / or vinyl groups (for example, vinyl ether groups, aromatic vinyl compounds, N-vinyl compounds, and allyl groups).
[0021] Examples of suitable (meth)acrylic acid groups include acrylate (HC=CHCO-), acrylamide (HC=CHCONH-), methacrylate (HC=C(CH)CO-), and methacrylamide (HC=C(CH)CONH-) groups. Acrylic acid groups are preferred over methacrylic acid groups because they are more reactive.
[0022] Preferred ethylenically unsaturated groups do not contain ester groups, as this can improve the stability and pH tolerance of the resulting composition. Preferred ethylenically unsaturated groups that do not contain ester groups include vinyl groups.
[0023] Examples of compounds that may be used as component (b) include:
[0024] [ka]
[0025] may be mentioned. The above-mentioned materials which may be used as component (b) can be obtained from commercial sources, for example, Sigma-Aldrich.
[0026] It is particularly preferred that component (b) is or comprises divinylbenzene, due to the low cost and wide availability of this compound (often as a mixture of isomers).
[0027] Preferably, the CEL composition comprises 10 to 60 wt %, more preferably 20 to 60 wt %, and most preferably 20 to 55 wt % of component (b). The molar ratio of component (a) to component (b) is preferably in the range of 3:1 to 1:2, more preferably 2:1 to 1:2, especially 2:1 to 1:1, respectively.
[0028] Component (c) is preferably inert, ie, unable to react with any of the other components of the CEL composition. Preferably, component (c) is miscible with the other components of the CEL composition, and thus component (c) may be used to dilute the other components of the CEL composition to provide a low viscosity CEL composition suitable for use in coating machines and equipment.
[0029] Examples of non-aqueous solvents that may be used as component (c) of the CEL composition include alcohol-based solvents, ether-based solvents, amide-based solvents, ketone-based solvents, sulfoxide-based solvents, sulfone-based solvents, nitrile-based solvents, and organic phosphorus-based solvents. Examples of alcohol-based solvents that may be used as or in component (c) include methanol, ethanol, isopropanol, n-butanol, ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, and mixtures containing two or more thereof. In addition, preferred inert organic solvents that may be used in component (c) include dimethyl sulfoxide, dimethylimidazolidinone, sulfolane, N-methylpyrrolidone, dimethylformamide, acetonitrile, acetone, 1,4-dioxane, 1,3-dioxolane, tetramethylurea, hexamethylphosphoramide, hexamethylphosphorotriamide, pyridine, propionitrile, butanone, cyclohexanone, tetrahydrofuran, tetrahydropyran, 2-methyltetrahydrofuran, ethylene glycol diacetate, cyclopentyl methyl ether, methyl ethyl ketone, ethyl acetate, y-butyrolactone, and mixtures containing two or more thereof. Dimethyl sulfoxide, N-methylpyrrolidone, dimethylformamide, dimethylimidazolidinone, sulfolane, acetone, cyclopentyl methyl ether, methyl ethyl ketone, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, and mixtures containing two or more thereof are preferred.
[0030] Other examples of component (c) of the CEL composition include non-polar aprotic solvents such as toluene, xylene, chloroform, dichloromethane, pyrrole, N-methylpyrrole, pyridine, pyrazine, and mixtures comprising two or more of the foregoing.
[0031] Preferably, the CEL composition contains a small amount of component (c), which allows the preparation of a highly concentrated CEL. If a large amount of component (c) is present in the CEL composition during curing, a film (or CEL) with an open structure may be formed, with component (c) filling the open spaces. After drying, such an open structure tends to swell in an aqueous environment, resulting in a decrease in permselectivity, which is undesirable.
[0032] Preferably, the CEL composition comprises 0 to 30 wt% of component (c), more preferably 4 to 20 wt%, especially 2 to 15 wt% of component (c). Component (d) of the CEL composition preferably is or includes a thermal initiator, a photoinitiator, or a combination thereof. Most preferably, component (d) is or includes a thermal initiator.
[0033] Examples of thermal initiators include 2,2'-azobis(2-methylpropionitrile) (AIBN), 4,4'-azobis(4-cyanovaleric acid), 2,2'-azobis(2,4-dimethylvaleronitrile), 2,2'-azobis(2-methylbutyronitrile), 1,1'-azobis(cyclohexane-1-carbonitrile), 2,2'-azobis(4-methoxy-2,4-dimethylvaleronitrile), dimethyl 2,2' -Azobis(2-methylpropionate), 2,2'-azobis[N-(2-propenyl)-2-methylpropionamide, 1-[(1-cyano-1-methylethyl)azo]formamide, 2,2'-azobis(N-butyl-2-methylpropionamide), 2,2'-azobis(N-cyclohexyl-2-methylpropionamide), 2,2'-azobis(2-methylpropionamidine) dihydrochloride , 2,2'-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride, 2,2'-Azobis[2-(2-imidazolin-2-yl)propane]disulfate dihydrate, 2,2'-Azobis[N-(2-carboxyethyl)-2-methylpropionamidine]hydrate, 2,2'-Azobis{2-[1-(2-hydroxyethyl)-2-imidazolin-2-yl]propane}dihydrochloride 2,2'-azobis[2-(2-imidazolin-2-yl)propane], 2,2'-azobis(1-imino-1-pyrrolidino-2-ethylpropane) dihydrochloride, 2,2'-azobis{2-methyl-N-[1,1-bis(hydroxymethyl)-2-hydroxyethyl]propionamide}, and 2,2'-azobis[2-methyl-N-(2-hydroxyethyl)propionamide].
[0034] Preferably, the CEL composition does not contain component (d) or contains 0.001 to 2 wt %, more preferably 0.2 to 1 wt %, of component (d). Component (d) is not required if the CEL composition is to be cured by electron beam (EB) or gamma irradiation.
[0035] Optionally, the CEL composition further comprises a small amount of component (e), which can be useful for providing the CEL with less hydrophilicity, which helps to accelerate the hydrolysis process. Examples of anionic monomers containing one and only one ethylenically unsaturated group that may be used as component (e) include sulfonated styrenes in the form of the free acid or a salt, in particular in the form of the lithium salt, the sodium salt, or a mixed salt of lithium and sodium.
[0036] Preferably, the CEL composition contains 0-15 wt %, more preferably less than 15 wt %, of component (e). In one embodiment, the CEL composition and / or the AEL composition comprises at least 60 wt% of the curable compound.
[0037] Preferably, the membrane of the present invention includes a porous support. The porous support may be included in the CEL, in the AEL, at the junction of the AEL and CEL, or at two or more of the aforementioned locations. Also, more than one porous support may be provided at each location.
[0038] Examples of porous supports include synthetic woven and nonwoven fabrics and extruded films. Examples include wet-laid and dry-laid nonwoven materials, spunbond fabrics, meltblown fabrics, and nanofiber webs made from polyethylene, polypropylene, polyacrylonitrile, polyvinyl chloride, polyphenylene sulfide, polyester, polyamide, polyaryletherketones such as polyetheretherketone, and copolymers thereof. The porous support may also be a porous membrane, such as a polysulfone membrane, a polyethersulfone membrane, a polyphenylene sulfone membrane, a polyphenylene sulfide membrane, a polyimide membrane, a polyetherimide membrane, a polyamide membrane, a polyamideimide membrane, a polyacrylonitrile membrane, a polycarbonate membrane, a polyacrylate membrane, a cellulose acetate membrane, a polypropylene membrane, a poly(4-methyl-1-pentene) membrane, a polyynylidene fluoride membrane, a polytetrafluoroethylene membrane, a polyhexafluoropropylene membrane, and a polychlorotrifluoroethylene membrane, and derivatives thereof.
[0039] The porous support preferably has an average thickness between 10 and 200 μm, more preferably between 20 and 150 μm. Preferably, the porous support has a porosity between 30 and 95%. The porosity of the support may be determined by a porometer, for example a Porolux™ 1000 from IB-FT GmbH, Germany.
[0040] If present, the porous support may be treated to modify its surface energy, for example to a value greater than 45 mN / m, preferably greater than 55 mN / m. Suitable treatments include, for example, corona discharge treatment, plasma glow discharge treatment, flame treatment, ultraviolet radiation treatment, or chemical treatment to improve wettability and adhesion to the porous support.
[0041] Commercially available porous supports are available from several sources, such as Freudenberg Filtration Technologies (Novatexx materials), Lydall Performance Materials, Celgard LLC, APorous Inc., SWM (Conwed Plastics, DelStar Technologies), Teijin, Hirose, Mitsubishi Paper Mills Ltd, and Sefar AG.
[0042] Preferably, the support is a polymeric support. Preferably, the support comprises a synthetic woven or nonwoven fabric or extruded film that does not have covalently attached ionic groups. The membrane according to the first aspect of the invention is preferably a bipolar membrane or a membrane that can be converted into a bipolar membrane by hydrolysis.
[0043] The AEL of the membranes of the present invention can preferably be prepared by curing a composition comprising a curable cationic compound (i.e., an "AEL composition"). Accordingly, the AEL composition preferably comprises a curable cationic compound (referred to in the compositions described below as component (a2)).
[0044] Preferred curable cationic compounds contain at least two ethylenically unsaturated groups, such as those represented by formula (II):
[0045] [ka]
[0046] (In the formula, L 1 is an alkylene or alkenylene group, R a , R b , R c , and R d are each independently an alkyl group or an aryl group; or R a and Rb , and / or R c and R d may form a ring together with the atoms to which they are attached, n1 and n2 each independently represent an integer of 1 to 10; X1 - and X2 - each independently represents an anion).
[0047] L 1 is preferably ethylene, propylene, hexylene, or vinylene. R a , R b , R c , and R d If any of the is an alkyl group, it is preferably C 1~4 alkyl groups, in particular methyl.
[0048] R a , R b , R c , and R d When any of is an aryl group, it is preferably C 6~10 - an aryl group, in particular phenyl. R a and R b , and / or R c and R d When they form a ring together with the atoms to which they are attached, the ring is preferably a five- or six-membered ring.
[0049] X1 - and X2 - are preferably each independently halo, especially Cl - is. Thus, the AEL composition preferably comprises the following components: (a2) a curable cationic compound containing at least two ethylenically unsaturated groups; and optionally (b2) a compound containing one and only one ethylenically unsaturated group; optionally (c2) a solvent; optionally (d2) a radical initiator; Includes.
[0050] Preferably, the AEL composition comprises at least one, more preferably at least two, especially all three of component (b2), component (c2), and component (d2). Examples of compounds of formula (II) include:
[0051] [ka]
[0052] Examples include: Synthetic methods can be found, for example, in EP3184558 and US2016 / 0001238.
[0053] The AEL composition preferably comprises 30-80 wt% of the compound of component (a2), more preferably between 40-70 wt% of the compound of component (a2). Preferably, the AEL composition comprises: (i) 30 to 80 wt% of component (a2); (ii) 0 to 40 wt% of component (b2); (iii) 10 to 40 wt% of component (c2) Includes.
[0054] Component (b2) preferably contains an aromatic group. Component (b2) preferably contains cationic groups. Examples of compounds that may be used as component (b2) of the AEL composition include the following:
[0055] [ka]
[0056] Examples include: The above compounds may be prepared, for example, as described in US2016177006.
[0057] Preferably, the molar ratio of component (a2) to component (b2) in the AEL composition is in the range of 9:1 to 1:4. The AEL composition comprises 0 to 60 wt %, more preferably 5 to 45 wt %, and most preferably 10 to 40 wt % of component (b2).
[0058] Component (c2) of the AEL composition preferably comprises water and, optionally, an organic solvent, particularly where some or all of the organic solvent is water-miscible. The water is useful for dissolving the compound of formula (II) and, if present, component (c2). The solvent is useful for reducing the viscosity and / or surface tension of the composition.
[0059] Examples of suitable solvents that may be used as component (c2) of the AEL composition include water, alcoholic solvents, etheric solvents, amide solvents, ketone solvents, sulfoxide solvents, sulfone solvents, nitrile solvents, organophosphorus solvents, and mixtures comprising two or more thereof. Examples of alcoholic solvents that may be used as component (ii) or in component (ii) (especially in combination with water) include methanol, ethanol, isopropanol, n-butanol, ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, and mixtures comprising two or more thereof. In addition, preferred inert organic solvents that may be used in component (ii) include dimethyl sulfoxide, dimethylimidazolidinone, sulfolane, N-methylpyrrolidone, dimethylformamide, acetonitrile, acetone, 1,4-dioxane, 1,3-dioxolane, tetramethylurea, hexamethylphosphoramide, hexamethylphosphorotriamide, pyridine, propionitrile, butanone, cyclohexanone, tetrahydrofuran, tetrahydropyran, 2-methyltetrahydrofuran, ethylene glycol diacetate, cyclopentyl methyl ether, methyl ethyl ketone, ethyl acetate, y-butyrolactone, and mixtures containing two or more thereof. Dimethyl sulfoxide, N-methylpyrrolidone, dimethylformamide, dimethylimidazolidinone, sulfolane, acetone, cyclopentyl methyl ether, methyl ethyl ketone, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, and mixtures containing two or more thereof are preferred.
[0060] In some embodiments, the AEL composition comprises 10 to 40 wt %, more preferably 10 to 35 wt %, and most preferably 15 to 30 wt % of component (c2). Examples of components (c2)-(d2) that may be included in the AEL composition used to form the AEL are as described above for the CEL composition as components (c) and (d), respectively. However, component (c2) of the AEL composition is preferably aqueous.
[0061] Component (d2) preferably is or comprises a thermal initiator, a photoinitiator, or a combination thereof. Most preferably, component (d) is or comprises a photoinitiator.
[0062] Examples of suitable photoinitiators that may be used as component (d2) of the AEL composition include aromatic ketones, acylphosphine compounds, aromatic onium salt compounds, organic peroxides, thio compounds, hexaarylbiimidazole compounds, ketoxime ester compounds, borate compounds, azinium compounds, metallocene compounds, active ester compounds, compounds having a carbon-halogen bond, and alkylamine compounds. Preferred examples of aromatic ketones, acylphosphine oxide compounds, and thio compounds include compounds having a benzophenone skeleton or a thioxanthone skeleton, as described in "RADIATION CURING IN POLYMER SCIENCE AND TECHNOLOGY," pp. 77-117 (1993).More preferred examples thereof include alpha-thiobenzophenone compounds described in JP1972-6416B (JP-S47-6416B), benzoin ether compounds described in JP1972-3981B (JP-S47-3981B), alpha-substituted benzoin compounds described in JP1972-22326B (JP-S47-22326B), and alpha-substituted benzoin compounds described in JP1972-23664B (JP-S47-23664B). benzoin derivatives described in JP1982-30704A (JP-S57-30704A), aroylphosphonic acid esters described in JP1985-26483B (JP-S60-26483B), dialkoxybenzophenones described in JP1985-26403B (JP-S60-26403B) and JP1987-81345A (JPS62-81345A), benzoin ethers described in JP1989-34242B (JP alpha-aminobenzophenones described in JP 1990-211452A (JP-H02-211452A), U.S. Pat. No. 4,318,791A, and EP 0284561A1, p-di(dimethylaminobenzoyl)benzene described in JP 1990-211452A (JP-H02-211452A), thio-substituted aromatic ketones described in JP 1986-194062A (JPS61-194062A), acylphosphine sulfides described in JP 1990-9597B (JP-H02-9597B), acylphosphines described in JP 1990-9596B (JP-H02-9596B), thioxanthones described in JP 1988-61950B (JP-S63-61950B), and coumarins described in JP 1984-42864B (JP-S59-42864B). In addition, the photoinitiators described in JP2008-105379A and JP2009-114290A are also preferred. In addition, the photoinitiators described in Kato Kiyomi, "Ultraviolet Curing System," pages 65-148 (Research Center Co., Ltd., 1989) may also be used.
[0063] Particularly preferred photoinitiators that may be used as component (d2) of the AEL composition include Norrish Type II photoinitiators that have a maximum absorption at wavelengths greater than 380 nm when measured in one or more of the following solvents: water, ethanol, and toluene at a temperature of 23° C. Examples include xanthene, flavin, curcumin, porphyrin, anthraquinone, phenoxazine, camphorquinone, phenazine, acridine, phenothiazine, xanthone, thioxanthone, thioxanthene, acridone, flavone, coumarin, fluorenone, quinoline, quinolone, naphthaquinone, quinolinone, arylmethane, azo, benzophenone, carotenoid, cyanine, phthalocyanine, dipyrrin, squarine, stilbene, styryl, triazine, or anthocyanin-derivatized photoinitiators.
[0064] The AEL composition preferably contains 0.001 to 2 wt %, more preferably 0.005 to 0.9 wt % of component (d2). The AEL composition and the CEL composition optionally each independently further comprise a polymerization inhibitor, which can be useful in making the compositions stable during storage and use.
[0065] As the polymerization inhibitor, well-known polymerization inhibitors can be used, examples of which include phenol compounds, hydroquinone compounds, certain amine compounds, mercapto compounds, and nitroxyl radical compounds.
[0066] Examples of phenolic compounds include hindered phenols (phenols having a t-butyl group at the ortho position, typically 2,6-di-t-butyl-4-methylphenol) and bisphenols. Specific examples of hydroquinone compounds include monomethyl ether hydroquinone. Specific examples of amine compounds include N-nitroso-N-phenylhydroxylamine and N,N-diethylhydroxylamine. Specific examples of nitroxyl radical compounds include 4-hydroxyTEMPO (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl free radical).
[0067] The AEL and CEL compositions optionally each independently further comprise two or more polymerization inhibitors. When the composition used to form the AEL or CEL contains a polymerization inhibitor, the content is preferably 0.01 to 5 wt %, more preferably 0.01 to 1 wt %, and even more preferably 0.01 to 0.5 wt %, relative to the total weight of the composition.
[0068] The AEL composition and the CEL composition optionally each independently further comprise a surfactant, a polymeric dispersant, and / or an anti-crater agent. Various polymer compounds may be included in the AEL and / or CEL composition films to adjust their physical properties. Suitable polymer compounds include acrylic polymers, polyurethane resins, polyamide resins, polyester resins, epoxy resins, phenolic resins, polycarbonate resins, polyvinyl butyral resins, polyvinyl formal resins, shellac, vinyl resins, acrylic resins, rubber resins, waxes, and natural resins, as well as combinations of two or more of the foregoing.
[0069] The AEL composition and the CEL composition may each independently further comprise a surfactant, such as a nonionic surfactant, a cationic surfactant, or an organic fluorosurfactant. Specific examples of surfactants include anionic surfactants (e.g., alkylbenzenesulfonates, alkylnaphthalenesulfonates, higher fatty acid salts, sulfonates of higher fatty acid esters, sulfate ester salts of higher alcohol ethers, sulfonates of higher alcohol ethers, alkyl carboxylate salts of higher alkylsulfonamides, and alkyl phosphate salts), and nonionic surfactants (e.g., poly(oxyethylene) alkyl ethers, poly(oxyethylene) alkylphenyl ethers, poly(oxyethylene) fatty acid esters, sorbitan fatty acid esters, ethylene oxide adducts of acetylene glycol, ethylene oxide adducts of glycerin, and polyoxyethylene sorbitan fatty acid esters). Other examples of suitable surfactants include amphoteric surfactants (e.g., alkylbetaines and amidobetaines), silicone surfactants, and fluorosurfactants. The surfactant may be suitably selected from surfactants known in the art or their derivatives.
[0070] The AEL composition and the CEL composition optionally each independently further comprise a polymeric dispersant. Specific examples of polymer dispersants include polyvinylpyrrolidone, polyvinyl alcohol, polyvinyl methyl ether, polyethylene oxide, polyethylene glycol, polypropylene glycol, and polyacrylamide. Among these, polyvinylpyrrolidone is preferably used.
[0071] The AEL and CEL compositions optionally each independently further comprise an anti-crater agent (sometimes called a surface conditioner), a leveling agent, or a slip agent to prevent unevenness on the CEL or AEL surface, examples of which include organo-modified polysiloxanes (mixtures of polyether siloxanes and polyethers), polyether-modified polysiloxane copolymers, and silicone-modified copolymers.
[0072] Examples of commercially available anti-crater agents that may be included in the compositions used to form the AEL and / or CEL include Tego Glide™ 432, Tego Glide™ 110, Tego Glide™ 130, Tego Glide™ 406, Tego Glide™ 410, Tego Glide™ 411, Tego Glide™ 415, Tego Glide™ 420, Tego Glide™ 435, Tego Glide™ 440, Tego Glide™ 450, Tego Glide™ 482, Tego Glide™ A115, Tego Glide™ B1484, and Tego Glide™ ZG400 (all trade names) manufactured by Evonik Industries GmbH.
[0073] The AEL and CEL compositions preferably each independently comprise 0 to 10 wt%, more preferably 0 to 5 wt%, especially 1 to 2 wt% of anti-crater agent (based on the total weight of the relevant composition).
[0074] In one embodiment, the film according to the present invention includes a catalyst. The catalyst may be included in the AEL composition and / or the CEL composition. For example, the catalyst can be applied to the AEL (as a post-treatment step) (e.g., before applying the CEL composition thereto) using, but not limited to, dipping, air knife coating, micro roller coating, spraying, chemical (vapor deposition) deposition, or physical (vapor deposition) deposition.
[0075] Examples of suitable catalysts include metal salts, metal oxides, organometallic compounds, monomers, polymers, or copolymers, including, but not limited to, FeCl3, FeCl2, AlCl3, MgCl2, RuCl3, CrCl3, Fe(OH)3, Al2O3, NiO, Zr(HPO4)2, MoS2, graphene oxide, Fe-polyvinyl alcohol complexes, polyvinyl alcohol (PVA), polyethylene glycol (PEG), polyethyleneimine (PEI), polyacrylic acid (PAA), copolymers of acrylic acid and maleic anhydride (PAAMA), and hyperbranched aliphatic polyesters, as well as combinations comprising two or more of the foregoing.
[0076] If the AEL or CEL composition includes a catalyst, the amount of catalyst is preferably up to 5 wt %, e.g., 0.001 wt % to 1 wt %, based on the weight of the relevant composition. If a catalyst is present in the AEL and / or CEL, the amount of catalyst is preferably up to 5 wt %, e.g., 0.001 wt % to 1 wt %.
[0077] According to a second aspect of the present invention, there is provided a method for producing a membrane, comprising the steps of: (i) applying an AEL composition to a substrate; (ii) at least partially curing the AEL composition, thereby forming an anion exchange layer (AEL); (iii) applying a CEL composition to the AEL; (iv) curing the CEL composition, thereby forming a cation exchange layer (CEL) on the AEL; A method is provided, comprising:
[0078] In step (ii), the AEL composition is preferably photocured, for example using ultraviolet light. Thus, preferably, component (d2) of the AEL composition is or comprises a photoinitiator.
[0079] In step (ii), the AEL composition is preferably cured to an extent such that the resulting AEL can be processed in a curable composition application station while still having unreacted ethylenically unsaturated groups available for crosslinking to the monomers of the CEL composition.
[0080] In step (iv), the CEL composition is preferably thermally cured, and therefore preferably, component (d) of the CEL composition is or comprises a thermal initiator. The temperature suitable for curing the CEL composition is 50 to 120°C, more preferably 50 to 100°C, and particularly 60 to 85°C.
[0081] Thermal curing of the CEL composition typically takes from a minute or more to several hours. Optionally, the CEL composition is sandwiched between polymer films to prevent evaporation of component (c), if present, and then cured.
[0082] In the method of the second aspect of the present invention, the composition is preferably applied sequentially in step (i) and step (iii), preferably by a manufacturing unit including a composition application station, one or more curing stations equipped with an irradiation source if the composition is photocurable, one or more curing stations equipped with one or more heat sources if the composition is heat curable, a film collection station, and means for moving the support from the composition application station to the curing station and to the film collection station.
[0083] The composition application station may be located upstream relative to the curing station, and the curing station may be located upstream relative to the membrane recovery station. Examples of application techniques include slot die coating, slide coating, air knife coating, roller coating, screen printing, and dipping. Depending on the technique used and the desired final specifications, it may be necessary to remove excess composition from the substrate, for example, by roll-to-roll squeeze, roll-to-blade or blade-to-roll squeeze, blade-to-blade squeeze, or removal using a coating bar.
[0084] Photocuring with ultraviolet or visible light is preferred, typically at 40-1500 mJ / cm 2 The thermal curing is preferably carried out at a temperature between 20°C and 100°C for a period of, for example, 0.01 hours to 24 hours.
[0085] Optionally, the method according to the second aspect further comprises the step of converting the groups X to hydroxyl groups, for example by hydrolysis. In this way, the membrane may be converted into a bipolar membrane, or a bipolar membrane with a greater number of acidic groups. Suitable hydrolysis methods include hydrolysis under acidic or alkaline conditions, for example using an acid (e.g., hydrochloric acid) or an alkali (e.g., a metal hydroxide, in particular sodium hydroxide or potassium hydroxide).
[0086] According to a third aspect of the present invention, there is provided a membrane comprising an anion exchange layer (AEL) and a layer comprising -SO2X groups, where X is as defined above. According to a fourth aspect of the present invention, there is provided a method for preparing a bipolar membrane comprising the step of hydrolyzing at least some of the -SO2X groups in a membrane according to the first aspect of the present invention to -SO2OH groups or salts thereof.
[0087] In one embodiment of the method of the fourth aspect of the present invention, the SO2X groups are hydrolyzed to -SO2OH groups (in the free acid or salt form) by contact with aqueous acid and / or alkali. Hydrolysis may be achieved, for example, by immersing the membrane of the first aspect of the present invention in aqueous acid and / or alkali, preferably at elevated temperature (e.g., 50-100°C). Hydrolysis is preferably carried out by contact with aqueous acid and / or alkali for a total period of 1 hour to 1 month, especially 5 hours to 1 week.
[0088] Optionally, the aqueous acid and / or alkali contains a surfactant. Optionally, the aqueous acid and / or alkali comprises a water-miscible organic solvent. Preferably, the aqueous acid and / or alkali is aqueous, especially at a strength of 0.05 to 1.0N.
[0089] Suitable acids include hydrochloric acid and sulfuric acid. Suitable alkalis include sodium carbonate, ammonium hydroxide, ammonium tetramethyl hydroxide, potassium hydroxide, and sodium hydroxide.
[0090] Optionally, the acid and / or alkali comprises a polar solvent, such as dimethyl sulfoxide, isopropyl alcohol, dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, ethylene carbonate, propylene carbonate, or two or more of the foregoing.
[0091] The extent of hydrolysis can be monitored over time by infrared spectroscopy. In one embodiment, the method of the second aspect or the fourth aspect of the invention further comprises the step (vi) of drying the obtained membrane, preferably at a temperature between 40°C and 200°C.
[0092] The membranes of the present invention may be produced by several alternative methods, including those described above. The membranes of the present invention may be used for a variety of applications, including electrodialysis and acid / base generation. The membranes of the present invention, including CEL and AEL, may also be used as bipolar membranes, particularly because they have good durability and low swelling in acidic and basic media and can be produced inexpensively, quickly, and efficiently. [Example]
[0093] The invention is further illustrated by the following examples in which all parts and percentages are by weight unless otherwise specified. The performance of the bipolar membrane according to the present invention was characterized by a plot of strength versus voltage. To measure this plot, a six-compartment cell was used. The first electrode compartment contained a platinum plate as the cathode and was separated from the second compartment by a CEM (CMX from Astom). The electrode compartments were filled with 0.5 M Na2SO4. A reference BPM (from Fumatech) was located between the second and third compartments. Both the second and third compartments contained 0.5 M NaCl solution. The BPM to be analyzed was located between the third and fourth compartments. The same reference BPM (from Fumatech) was located between the fourth and fifth compartments, and a CEM (CMX from Astom) was located between the fifth and sixth compartments. The fourth and fifth compartments were also filled with 0.5 M NaCl solution. The sixth compartment, containing a platinum plate as the anode, was the electrode compartment and contained 0.5 M Na2SO4.
[0094] Using the cell described above, the solution was measured at a temperature of 25°C and had a current of 600 A / m 2 A current density was applied and pumped through the chamber, and the bipolar voltage was measured using Haber-Luggin capillaries placed on either side of the BPM to be analyzed.
[0095] Electrical resistance The ER (ohm.cm) of the membranes (or their precursors) prepared in the examples by the method described by Dlugolecki et al., J. of Membrane Science, 319 (2008), pp. 217-218, with the following modifications. 2) was measured. The auxiliary membranes were CMX and AMX from Tokuyama Soda, Japan. The capillary and Ag / AgCl reference electrode (Metrohm type 6.0750.100) contained 3M KCl. The calibration solution and the liquid in chambers 2, 3, 4 and 5 were 0.5M NaCl solutions at 25°C. The effective membrane area is 9.62cm 2 was, The distance between the capillaries was 5.0 mm. The measurement temperature was 25°C. Cole Parmer Masterflex console drives (77521-47) with Easyload II model 77200-62 gear pumps were used for all chambers. The flow rate of each stream was 475 ml / min, controlled by a Porter Instrument flow meter (model 150AV-B250-4RVS) and a Cole Parmer flow meter (model G-30217-90). Prior to measurement, the samples were equilibrated in a 0.5 M solution of NaCl at room temperature for at least 1 hour. Preferably, the ER(NaCl) of the membrane is 5 ohms / cm 2 Lower.
[0096] selective permeability The permselectivity (%), which is the selectivity for the passage of ions of opposite charge to the charge of the membranes (or their precursors) prepared in the examples, was measured as follows: The membrane to be analyzed was placed in a two-chamber system: one chamber was filled with a 0.05 M solution of NaOH, and the other with a 0.5 M solution of NaOH.
[0097] setting · Capillary and Ag / AgCl reference electrode (Metrohm type 6.0750.100) contained 3 M KCl; The effective membrane area is 9.62cm 2 was; · The distance between the capillaries was approximately 15 mm; · The measured temperature was 21.0±0.2℃; · A Cole Parmer Masterflex console drive (77521-47) with an Easy Load II model 77200-62 gear pump was used for two chambers; The flow was controlled at a constant 500 ml / min using a Porter Instrument flow meter (model 150AV-B250-4RVS) and a Cole Parmer flow meter (model G-30217-90). Prior to the measurements, the membrane samples were equilibrated in 0.5 M NaOH solution for 1 h. After 20 min, the voltage was read from a standard VOM (multimeter). The PS(NaOH) of the membrane was preferably above 70%.
[0098] Infrared spectroscopy 910cm -1 The sulfonic acid group (-SO2OH or -SO2OM (M is Na)) of the alkyl-sulfonate ester group (-SO2X in formula (I)) can be identified by tracking the intensity of the peak at + , Li + , or K + Conventional IR measurements were used as a detection method to observe the hydrolysis to ). Spectra were collected on a PerkinElmer Frontier FT-IR spectrophotometer equipped with a diamond probe. Spectra were collected directly from the film after wiping off excess water.
[0099] NMR spectroscopy The structures of the compounds synthesized in the examples were determined using a Magritek Spincolve 60 Carbon (60 MHz, 4 scans) NMR spectrometer. 1 The results were confirmed by H-NMR. Samples for analysis were prepared by dissolving 5 wt % of each compound in deuterated solvents (as shown in the examples).
[0100] In the examples, the following abbreviations are used:
[0101] [Table 1]
[0102] [ka]
[0103] Synthesis of Et-DVBS
[0104] [ka]
[0105] Step 1 A solution of 2,4-divinylbenzenesulfonic acid sodium salt (145.15 g; 0.625 mol, 1 mol eq.) and TEMPOL (4-OH-TEMPO; 73 mg, ca. 500 ppm) in DMF (250 mL) was added dropwise within 1 h to thionyl chloride (318 mL, 520 g; 4.375 mol, 7 mol eq.) kept at 0 °C in an ice bath. After the addition was complete, the solution was slowly heated to room temperature and stirred for an additional 16 h. The reaction mixture was then slowly poured into ice / water (1.5 L). Toluene (600 mL) was added, and the entire mixture was filtered through Celite to remove undissolved material. The aqueous layer was extracted twice with toluene (300 mL), and the combined toluene layers were washed once with saturated KCl solution (500 mL). The toluene solution was dried over sodium sulfate, filtered, and concentrated in vacuo to give a yellow oil (about 120 grams; 84%). The crude product was used in the second step without further purification. 1 The synthesis was confirmed by 1 H NMR.
[0106] Step 2 A solution of the product obtained in Step 1 (120 g; 0.525 mol) and TEMPOL (4-OH-TEMPO; 60 mg, ca. 500 ppm) in pyridine (150 mL) was added dropwise to an ice-cooled (0 °C) and stirred solution of ethanol (46 mL, 36 g; 0.787 mol, 1.5 mol eq.) in pyridine (75 mL). After stirring for 2 h in an ice bath at 0 °C, the reaction mixture was poured into an ice-cooled mixture of ice and concentrated 36% HCl (1:1 ratio) (total volume 600 mL). Chloroform (ca. 800 mL) was added, and the mixture was transferred to a separatory funnel. The aqueous layer was removed, and the chloroform layer was washed successively with 3 M HCl solution and saturated NaCl solution. The chloroform layer was dried over sodium sulfate and filtered. TEMPOL (ca. 25 mg; ca. 200 ppm) was added to the filtrate which was then concentrated in vacuo to give an orange / brown oil (103 g; 82%). 1 The synthesis was confirmed by 1 H NMR.
[0107] Coating compositions containing EtSS, DVB, LiSS, a solvent, and 0.5 wt% V-65B were prepared according to compositions CELC1-4 described in Table 1. The compositions were coated onto a porous substrate, laminated between two PET foils, and then thermally cured in an oven at 70°C for 16 hours. The resulting CEM precursor films PF1-PF4 were then subjected to a hydrolysis process at 50°C. The hydrolysis conditions and the properties of the resulting cation exchange membranes (CEMs) are shown in Table 2.
[0108] [Table 2]
[0109] [Table 3]
[0110] Preparation of AEL An AEL composition (AELC1) was prepared containing 58 wt % 1,4-diazoniabicyclo[2.2.2]octane, 1,4-bis[(4-ethenylphenyl)methyl]-, chloride, 19 wt % water, 6 wt % IPA, 1 wt % Omnirad™ TPO-L, and 1 wt % Omnirad™ 1173. The AEL composition was coated onto a polyethylene nonwoven fabric and cured by UV to obtain the AEL. Coating of CEL and application to AEL to generate BPM The CEL compositions were prepared according to Table 3 below. Each CEL composition was coated onto the AEL prepared above, and then a second polyethylene nonwoven fabric was placed on the CEL composition layer and excess CEL composition was wiped off. The film was then placed between PET sheets and cured in an oven at 80°C for 16 hours. The resulting film was placed in a 0.1N NaOH solution containing 10% IPA for 72 hours to hydrolyze the -SO2X (ester) groups to the corresponding sulfonic acid sodium salts, yielding BPM.
[0111] The electrochemical and bipolar characteristics of these bipolar membranes were compared with reference membranes using the so-called current-voltage characteristics (IU curves), which measure the current density as a function of the applied voltage. Typically, at a given current density, i.e., 600 mA / cm 2 The lower the voltage (U) required to generate , the lower the ionic resistance of one or both of the ion exchange layers in particular, and of the bipolar membrane in general. In the case of a cation exchange layer, a low ionic resistance results in a more energy-efficient membrane.
[0112] [Table 4]
[0113] A comparative CEL composition (CExCELC1) was prepared, in which the CEL layer of the BPM was obtained from a composition consisting of 30 wt% Na-AMPS (calculated based on pure materials), 30 wt% M-11, 39 wt% water, and 1 wt% V-65B. In the comparative BPM, the AEL was prepared exactly as described for the inventive examples. The obtained BPM and its properties were as shown in Table 4 below.
[0114] [Table 5]
Claims
1. A membrane comprising an anion exchange layer (AEL) and a cation exchange layer (CEL), wherein the CEL is (a) Formula (I): 【Chemical 1】 (In the formula, X is a group of formula -OC n H 2n+1 , or -OC q H 2q-1 wherein n has a value of 1 to 6 and q has a value of 5 or 6; m has a value of 1 or 2; (b) a compound containing at least two ethylenically unsaturated groups; and optionally (c) a non-aqueous solvent; and optionally (d) a radical initiator; optionally (e) an anionic monomer containing one and only one ethylenically unsaturated group; A film obtainable by a method comprising the step of curing a curable composition comprising:
2. 10. The membrane of claim 1, wherein the membrane comprises a porous support, the porous support having an average thickness between 10 and 200 μm.
3. 3. The membrane of claim 1 or 2, wherein the curable composition from which the CEL is obtained comprises 20 to 88 wt % of component (a).
4. 4. The membrane of any one of claims 1 to 3, wherein the curable composition from which the CEL is obtained comprises 20 to 60 wt% of component (b).
5. 5. The membrane of claim 1, wherein component (b) comprises an aromatic group.
6. 6. The membrane of claim 1, wherein component (b) comprises at least two (meth)acrylic acid groups and / or vinyl groups.
7. 7. The membrane of claim 1, wherein the molar ratio of component (a) to component (b) is in the range of 2:1 to 1:
2.
8. A film according to any one of claims 1 to 7, wherein the AEL is obtained by curing a curable composition comprising a curable cationic compound comprising at least two ethylenically unsaturated groups.
9. The AEL comprises the following components: (a2) 30 to 80 wt % of a curable cationic compound containing at least two ethylenically unsaturated groups; (b2) 0 to 40 wt % of a compound containing one and only one ethylenically unsaturated group; (c2) 10 to 40 wt % of a solvent; (d2) 0.001 to 2 wt % of a radical initiator 9. The film according to claim 1, obtained by curing a composition comprising:
10. AEL is a compound of formula (II) 【Chemistry 2】 (In the formula, L 1 is an alkylene or alkenylene group, R a , R b , R c , and R d are each independently an alkyl group or an aryl group; or R a and R b , and / or R c and R d may form a ring together with the atoms to which they are attached, n1 and n2 each independently represent an integer of 1 to 10; X 1 - and X 2 - and each independently represent an anion.
11. 1. A method for producing a membrane, comprising: (i) applying an AEL composition to a substrate; (ii) at least partially curing the AEL composition, thereby forming an anion exchange layer (AEL); (iii) applying a CEL composition to the AEL; (iv) curing the CEL composition, thereby forming a cation exchange layer (CEL) on the AEL; forming a Including, 10. A method wherein the CEL composition comprises a compound of formula (I) as defined in any one of claims 1 to 6, and the AEL composition comprises a curable cationic compound.
12. At least some of the -SO in the compound of formula (I) 2 The X group may be -SO 2 12. The method of claim 11, further comprising hydrolyzing to an OH group or a salt thereof.
13. 13. The method of claim 11 or 12, wherein the AEL composition is as defined in any one of claims 8 to 10.
14. 11. The membrane of claim 1, which is a bipolar membrane.
15. 15. Use of a membrane according to any one of claims 1 to 10 or 14 for the production of acids and bases or for the generation of electricity.
Citation Information
Patent Citations
Polymer functional film and method for producing the same
JP2014208335A
Bipolar membrane, manufacturing method of the same, electrodialyzer and fuel battery
JP2018153763A
Multifunctional membrane and manufacturing method therefor
JP2019058843A
Photoelectric conversion element, photoelectric conversion module, and electronic apparatus
JP2019153763A
Polymer functional film, stack or device provided with polymer functional film, and method of producing polymer functional film
WO2016024465A1